Two Sigma Investments’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Two Sigma Investments's NEO Position: Q1 2026 in Review
Two Sigma Investments sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 170,900 shares — an estimated $2.01M sold.
Two Sigma Investments first reported a position in NEO in Q3 2014 and held it in 19 quarters. The position peaked at $11.9M in Q2 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Two Sigma Investments reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 170,900 NeoGenomics shares in Q1 2026, an estimated $2.01M.
- Two Sigma Investments first reported a position in NeoGenomics in Q3 2014 and held it in 19 quarters.
- Two Sigma Investments's NeoGenomics position peaked at $11.9M in Q2 2022.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.